|
ZITHROMAX
|
6505-01-455-4559
|
Azithromycin For Oral Suspension |
Pfizer Laboratories
|
|
Quote
|
|
98-0309
|
6505-01-455-4559
|
Azithromycin For Oral Suspension |
Defense Medical Standardization
|
|
Quote
|
|
NDC00069-3120-19
|
6505-01-455-4559
|
Azithromycin For Oral Suspension |
Pfizer Laboratories
|
|
Quote
|
|
0338-0550-02
|
6505-01-455-5193
|
Heparin Sodium In Dextrose Injec |
Baxter Government Customer Service
|
|
Quote
|
|
2B0802
|
6505-01-455-5193
|
Heparin Sodium In Dextrose Injec |
Baxter Government Customer Service
|
|
Quote
|
|
NDC0338-0550-02
|
6505-01-455-5193
|
Heparin Sodium In Dextrose Injec |
Baxter Government Customer Service
|
|
Quote
|
|
0338-0705-41
|
6505-01-455-5258
|
Potassium Chloride For Injection |
Baxter Government Customer Service
|
|
Quote
|
|
2B0821
|
6505-01-455-5258
|
Potassium Chloride For Injection |
Baxter Government Customer Service
|
|
Quote
|
|
NDC0338-0705-41
|
6505-01-455-5258
|
Potassium Chloride For Injection |
Baxter Government Customer Service
|
|
Quote
|
|
98-0223
|
6505-01-455-5535
|
Anticoagulant Citrate Dextrose S |
Defense Medical Standardization
|
|
Quote
|
|
8516000
|
6505-01-455-5535
|
Anticoagulant Citrate Dextrose S |
C. R. Bard, Inc.
|
|
Quote
|
|
8516000
|
6505-01-455-5535
|
Anticoagulant Citrate Dextrose S |
Davol Inc.
|
|
Quote
|
|
NDC00536-7620-94
|
6505-01-455-5537
|
Modifie Salicylic Acid Collodion |
Watson Pharma Inc
|
|
Quote
|
|
NDC00536-7620-94
|
6505-01-455-5537
|
Modifie Salicylic Acid Collodion |
Rugby Laboratories Inc
|
|
Quote
|
|
98-0382
|
6505-01-455-7944
|
Surgical Lubricant |
Defense Medical Standardization
|
|
Quote
|
|
NDC00168-0205-36
|
6505-01-455-7944
|
Surgical Lubricant |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC00168-0205-36
|
6505-01-455-7944
|
Surgical Lubricant |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
SURGILUBE
|
6505-01-455-7944
|
Surgical Lubricant |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
98-0381
|
6505-01-455-8428
|
Verapamil Hydrochloride Injectio |
Defense Medical Standardization
|
|
Quote
|
|
NDC00409-4011-01
|
6505-01-455-8428
|
Verapamil Hydrochloride Injectio |
Hospira, Inc.
|
|
Quote
|
|
ROCEPHIN
|
6505-01-455-9983
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
NDC00004-1964-02
|
6505-01-455-9983
|
Usp Ceftriaxone Sodium |
Roche Laboratories Inc.
|
|
Quote
|
|
98-0482
|
6505-01-456-2066
|
Usp Ipecac Syrup |
Defense Medical Standardization
|
|
Quote
|
|
NDC00395-1237-91
|
6505-01-456-2066
|
Usp Ipecac Syrup |
Humco Inc
|
|
Quote
|
|
98-0484
|
6505-01-456-2380
|
Scopolamine Transdermal System |
Defense Medical Standardization
|
|
Quote
|
|
NDC00067-4345-04
|
6505-01-456-2380
|
Scopolamine Transdermal System |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
98-0483
|
6505-01-456-2383
|
Lidocaine Hydrochloride And Epin |
Defense Medical Standardization
|
|
Quote
|
|
NDC63323-0483-20
|
6505-01-456-2383
|
Lidocaine Hydrochloride And Epin |
American Pharmaceutical Partners
|
|
Quote
|
|
IMITREX
|
6505-01-456-2497
|
Sumatriptan Succinate Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
98-0487
|
6505-01-456-2497
|
Sumatriptan Succinate Tablets |
Defense Medical Standardization
|
|
Quote
|
|
NDC16252-0591-99
|
6505-01-456-2497
|
Sumatriptan Succinate Tablets |
Watson Labs Inc
|
|
Quote
|
|
NDC00173-0459-00
|
6505-01-456-2497
|
Sumatriptan Succinate Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
98-0519
|
6505-01-456-3752
|
Cefdinir For Oral S |
Defense Medical Standardization
|
|
Quote
|
|
OMNICEF
|
6505-01-456-3752
|
Cefdinir For Oral S |
Parke-davis
|
|
Quote
|
|
NDC00781-6077-61
|
6505-01-456-3752
|
Cefdinir For Oral S |
Sandoz Pharmaceuticals Gmbh
|
|
Quote
|
|
NDC00074-3771-60
|
6505-01-456-3752
|
Cefdinir For Oral S |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC00071-2006-16
|
6505-01-456-3752
|
Cefdinir For Oral S |
Parke-davis
|
|
Quote
|
|
NDC00781-2176-60
|
6505-01-456-3754
|
Cefdinir Capsules |
Sandoz Pharmaceuticals Gmbh
|
|
Quote
|
|
NDC00074-3769-60
|
6505-01-456-3754
|
Cefdinir Capsules |
Abbott Laboratories Inc.
|
|
Quote
|
|
00093316006
|
6505-01-456-3754
|
Cefdinir Capsules |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
98-0520
|
6505-01-456-3756
|
Cefdinir For Oral S |
Defense Medical Standardization
|
|
Quote
|
|
OMNICEF
|
6505-01-456-3756
|
Cefdinir For Oral S |
Parke-davis
|
|
Quote
|
|
NDC00093-4136-73
|
6505-01-456-3756
|
Cefdinir For Oral S |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00071-2006-18
|
6505-01-456-3756
|
Cefdinir For Oral S |
Parke-davis
|
|
Quote
|
|
98-0622
|
6505-01-456-8888
|
Modi Rabies Vaccine |
Defense Medical Standardization
|
|
Quote
|
|
NDC63851-0501-01
|
6505-01-456-8888
|
Modi Rabies Vaccine |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
RABAVERT
|
6505-01-456-8888
|
Modi Rabies Vaccine |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
98-0530
|
6505-01-456-8889
|
Usp Calamine Lotion |
Defense Medical Standardization
|
|
Quote
|
|
NDC00395-0413-96
|
6505-01-456-8889
|
Usp Calamine Lotion |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC00395-0413-96
|
6505-01-456-8889
|
Usp Calamine Lotion |
Humco Holding Group, Inc
|
|
Quote
|
|
NDC45802-0130-82
|
6505-01-456-8889
|
Usp Calamine Lotion |
Clay-park Laboratories Inc
|
|
Quote
|
|
NDC000904-2533-21
|
6505-01-456-8889
|
Usp Calamine Lotion |
The Harvard Drug Group L.l.c.,
|
|
Quote
|
|
014283
|
6505-01-456-8889
|
Usp Calamine Lotion |
The Harvard Drug Group L.l.c.,
|
|
Quote
|
|
NDC00904-2533-21
|
6505-01-456-8889
|
Usp Calamine Lotion |
The Harvard Drug Group L.l.c.,
|
|
Quote
|
|
98-0638
|
6505-01-456-8957
|
Fenoldopam Mesylate |
Defense Medical Standardization
|
|
Quote
|
|
CORLOPAM
|
6505-01-456-8957
|
Fenoldopam Mesylate |
Defense Logistics Agency
|
|
Quote
|
|
NEUREX CORP.
|
6505-01-456-8957
|
Fenoldopam Mesylate |
Defense Logistics Agency
|
|
Quote
|
|
NDC62860-0003-01
|
6505-01-456-8957
|
Fenoldopam Mesylate |
Defense Logistics Agency
|
|
Quote
|
|
98-0639
|
6505-01-456-8976
|
Fenoldopam Mesylate |
Defense Logistics Agency
|
|
Quote
|
|
NDC00409-2304-02
|
6505-01-456-8976
|
Fenoldopam Mesylate |
Hospira, Inc.
|
|
Quote
|
|
CORLOPAM
|
6505-01-456-8987
|
Fenoldopam Mesylate |
Defense Logistics Agency
|
|
Quote
|
|
NDC00409-2304-01
|
6505-01-456-8987
|
Fenoldopam Mesylate |
Hospira, Inc.
|
|
Quote
|
|
98-0640
|
6505-01-456-8987
|
Fenoldopam Mesylate |
Defense Medical Standardization
|
|
Quote
|
|
13-9027-7
|
6505-01-456-9902
|
Concentrat Hemodialysis Solution |
Fresenius Usa, Inc.
|
|
Quote
|
|
OMNIPAQUE
|
6505-01-457-0274
|
Usp Iohexol Injection |
Amersham Health Inc.
|
|
Quote
|
|
Y418
|
6505-01-457-0274
|
Usp Iohexol Injection |
Amersham Health Inc.
|
|
Quote
|
|
NDC00407-1414-75
|
6505-01-457-0274
|
Usp Iohexol Injection |
Amersham Health Inc.
|
|
Quote
|
|
VISIPAQUE
|
6505-01-457-0458
|
Iodixanol Injection |
Amersham Health Inc.
|
|
Quote
|
|
V040
|
6505-01-457-0458
|
Iodixanol Injection |
Amersham Health Inc.
|
|
Quote
|
|
NDC00407-2223-01
|
6505-01-457-0458
|
Iodixanol Injection |
Amersham Health Inc.
|
|
Quote
|
|
OMNIPAQUE 350
|
6505-01-457-3290
|
Usp Iohexol Injection |
Amersham Health Inc.
|
|
Quote
|
|
1414-75
|
6505-01-457-3290
|
Usp Iohexol Injection |
Amersham Health Inc.
|
|
Quote
|
|
Y-415
|
6505-01-457-3290
|
Usp Iohexol Injection |
Amersham Health Inc.
|
|
Quote
|
|
13-9062-4
|
6505-01-457-3749
|
Concentrat Hemodialysis Solution |
Fresenius Usa, Inc.
|
|
Quote
|
